Typically,
pharmaceutical scientists start the discovery process by «screening» large libraries of chemical compounds in search of one or a few that might treat disease.
Not exact matches
But I think it's a disservice to gloss over the topic, because in reality it can be a fairly large hurdle for a successful industry transition,» said Andrew Spencer, a research
scientist at Alvine
Pharmaceuticals who has experience at biotech companies and small
start - ups.
After several false
starts, researchers at Vertex
Pharmaceuticals, in collaboration with others, developed a protease inhibitor known as telaprevir, while
scientists at Schering - Plough (which merged with Merck in 2009), created one called boceprevir.
Hamilton was a founding
scientist and VP of Scientific Operations for CellzDirect, a
start - up biotech company that specialized in providing cell products to the
pharmaceutical industry for safety testing.